4.5 Article

Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formation

Journal

NEUROBIOLOGY OF AGING
Volume 34, Issue 10, Pages 2399-2407

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2013.04.014

Keywords

mtDNA damage; Alzheimer; Plaque formation; APP cleavage; ROS

Funding

  1. National Institutes of Health [1R01AG036871, 1R01NS079965, 5R01EY010804]
  2. American Heart Association Grant [11Pre7610007]
  3. Lois Pope LIFE Fellowship
  4. [5T32NS007492]
  5. [5T32NS007459]

Ask authors/readers for more resources

Mitochondrial DNA (mtDNA) damage and the generation of reactive oxygen species have been associated with and implicated in the development and progression of Alzheimer's disease. To study how mtDNA damage affects reactive oxygen species and amyloid beta (A beta) pathology in vivo, we generated an Alzheimer's disease mouse model expressing an inducible mitochondrial-targeted endonuclease (Mito-PstI) in the central nervous system. Mito-PstI cleaves mtDNA causing mostly an mtDNA depletion, which leads to a partial oxidative phosphorylation defect when expressed during a short period in adulthood. We found that a mild mitochondrial dysfunction in adult neurons did not exacerbate Ab accumulation and decreased plaque pathology. Mito-PstI expression altered the cleavage pathway of amyloid precursor protein without increasing oxidative stress in the brain. These data suggest that mtDNA damage is not a primary cause of Ab accumulation. (C) 2013 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available